Skip to main content

Table 3 Summary of parameter values

From: Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model

Notation

Description

Value used

References

\(K_{T_{1}}\)

Half-saturation of CD 4+ T cells

2×10−3 g/cm3

Estimated

\(K_{T_{8}}\)

Half-saturation of CD 8+ T cells

1×10−3 g/cm3

Estimated

\(K_{T_{r}}\)

Half-saturation of Tregs

5×10−4 g/cm3

[65]

K C

Half-saturation of tumor cells

0.4 g/cm3

[65]

\(K_{I_{12}}\)

Half-saturation of IL-12

8×10−10 g/cm3

Estimated

\(K_{I_{2}}\)

Half-saturation of IL-2

2.37×10−11 g/cm3

[65]

\(K_{T_{\beta }}\)

Half-saturation of TGF- β

2.68×10−13 g/cm3

Estimated

\(K_{I_{6}}\)

Half-saturation of IL-6

3.4×10−11 g/cm3

Estimated

\(K_{I_{10}}\)

Half-saturation of IL-10

8.75×10−11 g/cm3

Estimated

\(K^{\prime }_{Q}\)

Half-saturation of PD-1-PD-L1

3.54×10−18 g2/cm6

Estimated

K B

Half-saturation of BRAF/MEKi

6.69×10−10 g/cm3

Estimated

\(K^{\prime }_{TQ}\)

Inhibition of function of T cells by PD-1-PD-L1

1.77×10−18 g2/cm6

Estimated

K CB

Inhibition of proliferation of cancer cells by BRAF/MEKi

3.06×10−9 g/cm3

Estimated